NatureWise Biotech & Medicals Corporation (4732.TWO)
TWD 20.05
(0.25%)
TWD 20.05
(0.25%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.43 Million TWD | -86.97% |
| 2022 | 26.34 Million TWD | -2.34% |
| 2021 | 26.97 Million TWD | -53.42% |
| 2020 | 57.92 Million TWD | 76.15% |
| 2019 | 32.88 Million TWD | 250.99% |
| 2018 | -21.77 Million TWD | 63.67% |
| 2017 | -59.95 Million TWD | 9.55% |
| 2016 | -66.28 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.69 Million TWD | 4.72% |
| 2024 Q2 | 2.69 Million TWD | 0.0% |
| 2023 Q2 | 861 Thousand TWD | 100.0% |
| 2023 FY | 3.43 Million TWD | -86.97% |
| 2023 Q3 | 1.28 Million TWD | 49.42% |
| 2023 Q1 | 430.5 Thousand TWD | -95.92% |
| 2023 Q4 | 2.57 Million TWD | 100.0% |
| 2022 Q2 | 15.78 Million TWD | 0.0% |
| 2022 Q4 | 10.55 Million TWD | 0.0% |
| 2022 FY | 26.34 Million TWD | -2.34% |
| 2021 Q2 | -15.48 Million TWD | 0.0% |
| 2021 Q4 | 42.45 Million TWD | 0.0% |
| 2021 FY | 26.97 Million TWD | -53.42% |
| 2020 FY | 57.92 Million TWD | 76.15% |
| 2020 Q4 | 8.38 Million TWD | 0.0% |
| 2020 Q2 | 49.53 Million TWD | 0.0% |
| 2019 Q4 | 22.18 Million TWD | 0.0% |
| 2019 FY | 32.88 Million TWD | 250.99% |
| 2018 FY | -21.77 Million TWD | 63.67% |
| 2017 FY | -59.95 Million TWD | 9.55% |
| 2016 FY | -66.28 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | 105.217% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 103.655% |
| Visgeneer Inc. | -21.15 Million TWD | 116.23% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | 104.04% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 103.679% |
| Sagittarius Life Science Corp | -64.37 Million TWD | 105.334% |
| NaviFUS Corp. | -76.42 Million TWD | 104.493% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 101.945% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | 105.478% |
| TaiRx, Inc. | -214.69 Million TWD | 101.599% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | 105.073% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 100.313% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | 151.952% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 100.914% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | 106.051% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 94.578% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 98.782% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 99.616% |
| RBC Bioscience Corporation | 14.53 Million TWD | 76.381% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | 104.865% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 98.972% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 95.744% |
| AP Biosciences Inc | -347.47 Million TWD | 100.988% |
| EirGenix Inc. | -1.03 Billion TWD | 100.333% |
| Enimmune corporation | -243.47 Million TWD | 101.41% |
| Lukas Biomedical Inc. | -43.56 Million TWD | 107.883% |
| GlycoNex Incorporation | -259.86 Million TWD | 101.321% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 100.495% |
| Level Biotechnology Inc. | 67.55 Million TWD | 94.917% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | 221.601% |
| TaiMed Biologics Inc. | -166.23 Million TWD | 102.066% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 100.57% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | 107.547% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | 108.278% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | 252.419% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 85.788% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | 104.043% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | 102.025% |
| Neith Corporation | -48.85 Million TWD | 107.029% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | 104.763% |
| VBI | -16.13 Million TWD | 121.287% |
| BiOptic Inc. | 44.05 Million TWD | 92.205% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 98.983% |
| Sinew Pharma Inc. | -186.25 Million TWD | 101.844% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 97.851% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | 101.498% |
| CHO Pharma, Inc. | -268.99 Million TWD | 101.277% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 100.278% |
| 3D Global Biotech Inc. | -62.85 Million TWD | 105.464% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | 101.104% |
| Intech Biopharm Corporation | -304.39 Million TWD | 101.128% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 100.313% |
| TCI GENE Inc. | 10.04 Million TWD | 65.827% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 102.698% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 101.618% |
| PharmaEngine, Inc. | 277.18 Million TWD | 98.761% |
| Savior Lifetec Corporation | -2.42 Million TWD | 241.901% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 101.966% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 100.164% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | 102.788% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 100.283% |
| Acepodia, Inc. | -435.97 Million TWD | 100.788% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 100.704% |